GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Grand Brilliance Group Holdings Ltd (HKSE:08372) » Definitions » Market Cap

Grand Brilliance Group Holdings (HKSE:08372) Market Cap : HK$88.80 Mil (As of Jun. 05, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Grand Brilliance Group Holdings Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Grand Brilliance Group Holdings's share price for the quarter that ended in Sep. 2023 was HK$0.078. Grand Brilliance Group Holdings's Shares Outstanding (EOP) for the quarter that ended in Sep. 2023 was 800.00 Mil. Therefore, Grand Brilliance Group Holdings's market cap for the quarter that ended in Sep. 2023 was HK$62.40 Mil.

Grand Brilliance Group Holdings's quarterly market cap increased from Mar. 2023 (HK$56.80 Mil) to Jun. 2023 (HK$64.80 Mil) but then declined from Jun. 2023 (HK$64.80 Mil) to Sep. 2023 (HK$62.40 Mil).

Grand Brilliance Group Holdings's annual market cap declined from Mar. 2021 (HK$64.00 Mil) to Mar. 2022 (HK$59.20 Mil) and declined from Mar. 2022 (HK$59.20 Mil) to Mar. 2023 (HK$56.80 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Grand Brilliance Group Holdings's Enterprise Value for Today is HK$37.74 Mil.


Grand Brilliance Group Holdings Market Cap Historical Data

The historical data trend for Grand Brilliance Group Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grand Brilliance Group Holdings Market Cap Chart

Grand Brilliance Group Holdings Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Market Cap
Get a 7-Day Free Trial 96.00 56.00 64.00 59.20 56.80

Grand Brilliance Group Holdings Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 62.40 60.00 56.80 64.80 62.40

Competitive Comparison of Grand Brilliance Group Holdings's Market Cap

For the Medical Distribution subindustry, Grand Brilliance Group Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grand Brilliance Group Holdings's Market Cap Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Grand Brilliance Group Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where Grand Brilliance Group Holdings's Market Cap falls into.



Grand Brilliance Group Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Grand Brilliance Group Holdings's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as

Market Cap (A: Mar. 2023 )=Share Price (A: Mar. 2023 )*Shares Outstanding (EOP) (A: Mar. 2023 )
=HK$0.071*800
=HK$56.80

Grand Brilliance Group Holdings's Market Cap for the quarter that ended in Sep. 2023 is calculated as

Market Cap (Q: Sep. 2023 )=Share Price (Q: Sep. 2023 )*Shares Outstanding (EOP) (Q: Sep. 2023 )
=HK$0.078*800
=HK$62.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Grand Brilliance Group Holdings  (HKSE:08372) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Grand Brilliance Group Holdings Market Cap Related Terms

Thank you for viewing the detailed overview of Grand Brilliance Group Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Grand Brilliance Group Holdings (HKSE:08372) Business Description

Traded in Other Exchanges
N/A
Address
6 Sha Tsui Road, The Octagon, Units 2901-2903 and 2905, 29th Floor, New Territories, Tsuen Wan, Hong Kong, HKG
Grand Brilliance Group Holdings Ltd is an investment holding. The company is engaged in the business of medical device distribution. The company also provides one-stop medical device solutions, including market trend analysis, sourcing of medical devices, after-sale services, technical support, and training services, medical device leasing services, and quality assurance. Geographically, the company derives revenue from Hong Kong. The company serves private hospitals, public hospitals, private clinics, non-profit organizations, universities, and individual end-users in Hong Kong.
Executives
Miu Yin Shun Andrew 2202 Interest of your spouse
Wong Bik Kwan Bikie 2101 Beneficial owner
B&a Success Limited 2101 Beneficial owner

Grand Brilliance Group Holdings (HKSE:08372) Headlines

No Headlines